Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 5, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 1
| |||||||
Biomarin Pharmaceutical Inc
| 2.18K |
—
|
—
|
∞
| 2.18K |
Dec 27
| |||||||
Biomarin Pharmaceutical Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Turning Point Therapeutics, Inc.
| -110.96K |
$76.00 | -$8,432,884.00 | -100.00% |
0
|
Aug 17
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 26
| |||||||
Turning Point Therapeutics, Inc.
| 59.43K |
$36.30 | -$107,847.30 | +116.75% | 110.33K |
Feb 9
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 29
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 27
| |||||||
Turning Point Therapeutics, Inc.
|
0
|
$70.34 | -$8,057,037.74 |
—
| 50.2K |
Feb 9 - Feb 11
|
Scheduled
| ||||||
Turning Point Therapeutics, Inc.
| 22.62K |
—
|
—
| +82.01% | 50.2K |
Feb 8
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Turning Point Therapeutics, Inc.
| 4.17K |
$60.00 | $249,960.00 | +18.35% | 26.87K |
May 21
| |||||||
Passage Bio, Inc.
| 10K |
$14.98 | $149,750.00 | +112.36% | 18.9K |
Mar 24
| |||||||
Passage Bio, Inc.
| 8.9K |
$18.00 | $160,200.00 |
∞
| 8.9K |
Mar 3
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 27
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Turning Point Therapeutics, Inc.
| 706 |
$31.13 | $21,975.66 | +3.21% | 22.71K |
Dec 10 - Jan 6
| |||||||
Turning Point Therapeutics, Inc.
| 10K |
$45.00 | $450,000.00 | +83.33% | 22K |
Sep 10
| |||||||
Trovagene, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Iovance Biotherapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Turning Point Therapeutics, Inc.
| 12K |
$18.00 | $216,000.00 |
∞
| 12K |
Apr 22
| |||||||
Turning Point Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 15
| ||||||
Trovagene, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jan 23
| |||||||
Trovagene, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adverum Biotechnologies, Inc.
| 150K |
—
|
—
|
∞
| 150K | +1 |
Jun 19
| ||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Halozyme Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Halozyme Therapeutics Inc
| 11.6K |
$12.26 | -$84,594.00 | +42.20% | 39.08K |
Feb 3
| |||||||
Halozyme Therapeutics Inc
| 7.5K |
—
|
—
| +37.54% | 27.48K |
Jan 5
| |||||||
Halozyme Therapeutics Inc
| 6.34K |
$8.63 | -$923.41 | +46.51% | 19.98K |
Jun 30
| |||||||
Halozyme Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 3
| |||||||
Halozyme Therapeutics Inc
| 4.24K |
$16.39 | -$53,382.23 | +45.16% | 13.64K |
Jan 5
| |||||||
Halozyme Therapeutics Inc
| 9.39K |
$17.33 | -$98,001.15 |
∞
| 9.39K |
Dec 31
| |||||||
Halozyme Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jan 5
| |||||||
Halozyme Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.